March 28, 2025
The Boilermakers’ Sweet 16 contest tonight in the NCAA tournament provides a great opportunity to reflect on a basketball season that included a special focus on the Purdue University College of Veterinary Medicine’s Comparative Oncology Program. During the football and basketball season, a BIG Impact Research video spotlighting Purdue canine cancer research and treatment aired during Purdue games on the Big Ten Network.
February 7, 2025
The striking similarities between invasive bladder cancer in dogs and humans have fueled research advances for more than three decades. Most of that work has looked at separate aspects of the disease — risk factors, early detection, symptoms, treatment and gene expression. But a new project at Purdue University that combines many types of available data in a “digital twin” model of bladder cancer may prove powerful enough to predict patient outcomes, starting with the probability of metastasis.
January 21, 2025
A husband-wife team of veterinary oncologists with expertise in tumor ablation devices is now part of the Purdue University College of Veterinary Medicine’s Department of Veterinary Clinical Sciences and the Evan and Sue Ann Werling Comparative Oncology Research Center. Dr. Nick Dervisis and Dr. Shawna Klahn started in their new roles as Purdue associate professors of comparative oncology August 12 as part of the university’s Moveable Dream Hires program.
January 21, 2025
For Dr. Ourania Andrisani, Distinguished Professor of Basic Medical Sciences, understanding the complexities of liver cancer has been a defining passion throughout her career. Her work marks a critical step toward developing more effective treatments for this devastating disease.
November 22, 2024
The Purdue University College of Veterinary Medicine, in partnership with Akston Biosciences Corporation, has initiated the enrollment of dogs with urinary bladder cancer in a clinical trial of a pioneering immunotherapy. The strategic partnership between Purdue and Akston was announced in August after the underlying technology was developed at the College of Veterinary Medicine and the Purdue Institute for Cancer Research (PICR).
August 30, 2024
A husband-wife team of veterinary oncologists with expertise in tumor ablation devices is now part of the Purdue University College of Veterinary Medicine’s Department of Veterinary Clinical Sciences and the Evan and Sue Ann Werling Comparative Oncology Research Center.
August 16, 2024
Akston Biosciences Corporation, which is dedicated to accelerating the biologics revolution in Animal Health, and Purdue University have announced a strategic partnership to co-develop an anti-cPD-L1 monoclonal antibody (mAb) immunotherapy to treat cancer in dogs. The underlying technology was developed at the Purdue University College of Veterinary Medicine and the Purdue Institute for Cancer Research (PICR).
July 31, 2024
A long-term study that tracked the health of Scottish terriers indicates cigarette smoke exposure leads to a sixfold increase in the risk of bladder cancer
July 26, 2024
Unceasingly optimistic. That’s how colleagues describe Dr. Marejka Shaevitz, clinical assistant professor of oncology in the Purdue University College of Veterinary Medicine’s Department of Veterinary Clinical Sciences and the Werling Comparative Oncology Research Center. Dr. Shaevitz, who completed a three-year residency program in comparative oncology at Purdue in 2020, returned to the College of Veterinary Medicine in February, expanding the number of medical oncology faculty in the Department Veterinary Clinical Sciences. Her story is one that involves facing difficult loss and challenging diagnoses herself – turning points in her life that led her on the path toward a career in veterinary oncology.
June 14, 2024
A faculty member in Purdue Veterinary Medicine’s Department of Veterinary Clinical Sciences, Dr. Michael Childress, has been appointed as the Evan and Sue Ann Werling Professor of Comparative Oncology.
